These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27017551)

  • 1. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
    Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
    Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
    Kaur J; Sundar S; Singh N
    J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase.
    Bibi M; Qureshi NA; Sadiq A; Farooq U; Hassan A; Shaheen N; Asghar I; Umer D; Ullah A; Khan FA; Salman M; Bibi A; Rashid U
    Eur J Med Chem; 2021 Jan; 210():112986. PubMed ID: 33187806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
    Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
    ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
    Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
    Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
    Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
    Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
    Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents.
    Atta KFM; Ibrahim TM; Farahat OOM; Al-Shargabi TQ; Marei MG; Bekhit AA; El Ashry ESH
    Future Med Chem; 2017 Oct; 9(16):1913-1929. PubMed ID: 29028366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
    Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents.
    Taha M; Ismail NH; Imran S; Anouar EH; Selvaraj M; Jamil W; Ali M; Kashif SM; Rahim F; Khan KM; Adenan MI
    Eur J Med Chem; 2017 Jan; 126():1021-1033. PubMed ID: 28012342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.